Unique ID issued by UMIN | UMIN000015461 |
---|---|
Receipt number | R000017957 |
Scientific Title | Feasibility study on detecting EGFR T790M mutation in cell free DNA from advanced non small cell lung cancer patients refractory to EGFR-TKI:WJOG8014LTR |
Date of disclosure of the study information | 2014/10/17 |
Last modified on | 2018/03/13 16:28:33 |
Feasibility study on detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI:WJOG8014LTR
Feasibility study on detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI
Feasibility study on detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI:WJOG8014LTR
Feasibility study on detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI
Japan |
Advanced non-small cell lung cancer with EGFR mutation
Pneumology | Hematology and clinical oncology |
Malignancy
YES
To evaluate the procedure for detecting EGFR T790M mutation in cell free DNA from advanced non small cell lung cancer patients refractory to EGFR-TKI
Others
o evaluate the feasibility of detecting EGFR T790M mutation in cell free DNA from advanced non-small cell lung cancer patients
feasibility of detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI
detection rate of EGFR T790M mutations in plasma
concordance of EGFR mutation status between tissue sample and plasma
correlation between EGFR mutation status and clinical background
Observational
Not applicable |
Not applicable |
Male and Female
1) advanced non-small cell lung cancer harboring EGFR mutations
2) refractory to EGFR-TKI monotherapy or combination therapy
* accept patients receiving EGFR-TKI therapy beyond PD with or without local therapy such as radiation therapy for brain or bone metastasis
3) written informed consent obtained from the patient
Not applicable
155
1st name | |
Middle name | |
Last name | Kazuto Nishio |
Kinki University
Faculty of Medicine, Dept. of Genome Biology
377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511
072-366-0221
knishio@med.kindai.ac.jp
1st name | |
Middle name | |
Last name | Shinichiro Nakamura |
West Japan Oncology Group
datacenter
Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka 556-0016 JAPAN
06-6633-7400
datacenter@wjog.jp
West Japan Oncology Group
Astellas Pharma Inc.
Profit organization
Kinki University Faculty of Medicine, Dept. of Genome Biology
NO
2014 | Year | 10 | Month | 17 | Day |
Published
https://www.ncbi.nlm.nih.gov/pubmed/27542267
Completed
2014 | Year | 09 | Month | 14 | Day |
2014 | Year | 11 | Month | 04 | Day |
Nothing particular
2014 | Year | 10 | Month | 17 | Day |
2018 | Year | 03 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017957
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |